|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-12-27
|
|
pubmed:abstractText |
To evaluate the outcomes of patients with stage IB1-IIA cervical adenocarcinoma treated by various modalities in order to formulate a better treatment strategy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1879-3479
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
135-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21130445-Adenocarcinoma,
pubmed-meshheading:21130445-Adult,
pubmed-meshheading:21130445-Aged,
pubmed-meshheading:21130445-Aged, 80 and over,
pubmed-meshheading:21130445-Antineoplastic Agents,
pubmed-meshheading:21130445-Combined Modality Therapy,
pubmed-meshheading:21130445-Female,
pubmed-meshheading:21130445-Humans,
pubmed-meshheading:21130445-Middle Aged,
pubmed-meshheading:21130445-Neoplasm Recurrence, Local,
pubmed-meshheading:21130445-Neoplasm Staging,
pubmed-meshheading:21130445-Prognosis,
pubmed-meshheading:21130445-Radiotherapy, Adjuvant,
pubmed-meshheading:21130445-Retrospective Studies,
pubmed-meshheading:21130445-Risk Factors,
pubmed-meshheading:21130445-Treatment Outcome,
pubmed-meshheading:21130445-Uterine Cervical Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma.
|
|
pubmed:affiliation |
Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
